🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yanfang Liu

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0009-0004-5562-6569
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study”.

Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study

The Lancet Oncology(2025)10.1016/s1470-2045(25)00099-3
N/A
0.741DataRank · unranked
27 citations

Othon Iliopoulos, Kathryn E. Beckermann, Vivek Narayan, Benjamin L Maughan, Stéphane Oudard +9 more

Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2592
N/A
0DataRank · unranked
28 citations

Eric Jonasch, Othon Iliopoulos, Kathryn E. Beckermann, Vivek Narayan, Benjamin L. Maughan +10 more

Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Disease

European Urology(2025)10.1016/j.eururo.2025.03.002
N/A
0DataRank · unranked
8 citations

Cathy Anne Pinto, Yanfang Liu, Kristin Choo, Rabindra Gautam, Claire Fox +15 more

Corrigendum

Ophthalmology(2025)10.1016/j.ophtha.2024.12.032
N/A
0DataRank · unranked
0 citations

Ramaprasad Srinivasan, Jodi K. Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen, A. Kruse +13 more